Journal article
Drivers of mortality in patients with chronic coronary disease in the low-dose colchicine 2 trial
Abstract
BACKGROUND: Low-dose colchicine significantly reduces the risk of cardiovascular events in patients with chronic coronary disease. An increase of non-cardiovascular death raised concerns about its safety. This study reports cause-specific mortality and baseline predictors of mortality in the Low-Dose Colchicine 2 (LoDoCo2) trial.
METHODS: Patients with chronic coronary disease were randomly allocated to colchicine 0.5 mg once daily or placebo …
Authors
Opstal TSJ; Nidorf SM; Fiolet ATL; Eikelboom JW; Mosterd A; Bax WA; Budgeon CA; Ronner E; Prins FJ; Tijssen JGP
Journal
International Journal of Cardiology, Vol. 372, , pp. 1–5
Publisher
Elsevier
Publication Date
2 2023
DOI
10.1016/j.ijcard.2022.12.026
ISSN
0167-5273